Production and Supply of α-Particle-Emitting Radionuclides for Targeted α-Therapy.

Valery Radchenko, Alfred Morgenstern,Amir R Jalilian, Caterina F Ramogida, Cathy Cutler, Charlotte Duchemin, Cornelia Hoehr, Ferrid Haddad, Frank Bruchertseifer, Haavar Gausemel, Hua Yang,Joao Alberto Osso,Kohshin Washiyama, Kenneth Czerwinski, Kirsten Leufgen, Marek Pruszyński, Olga Valzdorf, Patrick Causey,Paul Schaffer, Randy Perron, Samsonov Maxim, D Scott Wilbur, Thierry Stora, Yawen Li

Journal of nuclear medicine : official publication, Society of Nuclear Medicine（2021）

Cited 53|Views4

No score

Abstract

Encouraging results from targeted α-therapy have received significant attention from academia and industry. However, the limited availability of suitable radionuclides has hampered widespread translation and application. In the present review, we discuss the most promising candidates for clinical application and the state of the art of their production and supply. In this review, along with 2 forthcoming reviews on chelation and clinical application of α-emitting radionuclides, The Journal of Nuclear Medicine will provide a comprehensive assessment of the field.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined